Michael Ackermann

Insider Reports History

Entity
Individual
Location
202 Carnegie Center, Suite 109, Princeton, NJ
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Ackermann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director Restricted Stock Units 12K $196K $16.31 Jun 16, 2022 Direct
Tarsus Pharmaceuticals, Inc. Director Stock Option (right to buy) 7K $76.9K $10.99 Jun 16, 2022 Direct

Insider Reports Filed by Michael Ackermann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARS Tarsus Pharmaceuticals, Inc. Jun 16, 2022 2 $0 4 Jul 1, 2022 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
TARS Tarsus Pharmaceuticals, Inc. May 5, 2022 1 $1.35M 4 May 9, 2022 Director
TARS Tarsus Pharmaceuticals, Inc. Dec 1, 2021 4 -$144K 4 Dec 3, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Nov 1, 2021 2 -$162K 4 Nov 3, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Oct 12, 2021 2 -$148K 4 Oct 14, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Oct 8, 2021 1 -$5.01K 4 Oct 12, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Sep 1, 2021 1 -$147K 4 Sep 3, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Aug 11, 2021 1 -$15.6K 4 Aug 12, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Aug 6, 2021 2 -$95.7K 4 Aug 10, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Aug 5, 2021 3 -$34.6K 4 Aug 6, 2021 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 15, 2021 4 $0 4 Jun 17, 2021 Director